BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiang N, Dalli J, Colas RA, Serhan CN. Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J Exp Med 2015;212:1203-17. [PMID: 26195725 DOI: 10.1084/jem.20150225] [Cited by in Crossref: 200] [Cited by in F6Publishing: 195] [Article Influence: 28.6] [Reference Citation Analysis]
Number Citing Articles
1 Yin P, Wei Y, Wang X, Zhu M, Feng J. Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury. Front Neurol 2018;9:617. [PMID: 30131754 DOI: 10.3389/fneur.2018.00617] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Vartak T, Godson C, Brennan E. Therapeutic potential of pro-resolving mediators in diabetic kidney disease. Adv Drug Deliv Rev 2021;178:113965. [PMID: 34508793 DOI: 10.1016/j.addr.2021.113965] [Reference Citation Analysis]
3 Kasikara C, Doran AC, Cai B, Tabas I. The role of non-resolving inflammation in atherosclerosis. J Clin Invest 2018;128:2713-23. [PMID: 30108191 DOI: 10.1172/JCI97950] [Cited by in Crossref: 92] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
4 Feehan KT, Gilroy DW. Is Resolution the End of Inflammation? Trends in Molecular Medicine 2019;25:198-214. [DOI: 10.1016/j.molmed.2019.01.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
5 Li C, Wu X, Liu S, Shen D, Zhu J, Liu K. Role of Resolvins in the Inflammatory Resolution of Neurological Diseases. Front Pharmacol 2020;11:612. [PMID: 32457616 DOI: 10.3389/fphar.2020.00612] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
6 Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review. Life Sci 2018;203:255-67. [PMID: 29715470 DOI: 10.1016/j.lfs.2018.04.049] [Cited by in Crossref: 285] [Cited by in F6Publishing: 210] [Article Influence: 71.3] [Reference Citation Analysis]
7 Zhang L, Qiu C, Yang L, Zhang Z, Zhang Q, Wang B, Wang X. GPR18 expression on PMNs as biomarker for outcome in patient with sepsis. Life Sci 2019;217:49-56. [PMID: 30503722 DOI: 10.1016/j.lfs.2018.11.061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
8 Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273-1288. [PMID: 28087575 DOI: 10.1096/fj.201601222r] [Cited by in Crossref: 282] [Cited by in F6Publishing: 158] [Article Influence: 56.4] [Reference Citation Analysis]
9 Oehler B, Mohammadi M, Perpina Viciano C, Hackel D, Hoffmann C, Brack A, Rittner HL. Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats. Front Mol Neurosci 2017;10:242. [PMID: 28824373 DOI: 10.3389/fnmol.2017.00242] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron 2018;100:1292-311. [PMID: 30571942 DOI: 10.1016/j.neuron.2018.11.009] [Cited by in Crossref: 172] [Cited by in F6Publishing: 168] [Article Influence: 57.3] [Reference Citation Analysis]
11 Khaddaj-Mallat R, Sirois C, Sirois M, Rizcallah E, Marouan S, Morin C, Rousseau É. Pro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi. PLoS One 2016;11:e0167058. [PMID: 27935998 DOI: 10.1371/journal.pone.0167058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
12 Bennett M, Gilroy DW. Lipid Mediators in Inflammation. Microbiol Spectr 2016;4. [PMID: 27837747 DOI: 10.1128/microbiolspec.MCHD-0035-2016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
13 Jannaway M, Torrens C, Warner JA, Sampson AP. Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619. Br J Pharmacol 2018;175:1100-8. [PMID: 29352769 DOI: 10.1111/bph.14151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
14 Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of anti-ageing? Semin Immunol 2018;40:36-48. [PMID: 30293857 DOI: 10.1016/j.smim.2018.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
15 Rana T, Behl T, Sehgal A, Mehta V, Singh S, Kumar R, Bungau S. Integrating Endocannabinoid Signalling In Depression. J Mol Neurosci 2021. [PMID: 33471311 DOI: 10.1007/s12031-020-01774-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 35.7] [Reference Citation Analysis]
17 Dubé L, Spahis S, Lachaîne K, Lemieux A, Monhem H, Poulin S, Randoll C, Travaillaud E, Ould-chikh N, Marcil V, Delvin E, Levy E. SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0156] [Reference Citation Analysis]
18 Thoene M, Van Ormer M, Yuil-Valdes A, Bruett T, Natarajan SK, Mukherjee M, Thompson M, Nordgren TM, Van Lippevelde W, Overby NC, Adu-Bonsaffoh K, Anderson-Berry A, Hanson C. Fat-soluble nutrients and Omega-3 fatty acids as modifiable factors influencing preterm birth risk. Placenta 2020;98:38-42. [PMID: 33039030 DOI: 10.1016/j.placenta.2019.12.002] [Reference Citation Analysis]
19 Stampanoni Bassi M, Gilio L, Maffei P, Dolcetti E, Bruno A, Buttari F, Centonze D, Iezzi E. Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression. Front Mol Neurosci 2018;11:424. [PMID: 30515077 DOI: 10.3389/fnmol.2018.00424] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
20 Sugimoto MA, Vago JP, Perretti M, Teixeira MM. Mediators of the Resolution of the Inflammatory Response. Trends in Immunology 2019;40:212-27. [DOI: 10.1016/j.it.2019.01.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 19.7] [Reference Citation Analysis]
21 Biringer RG. A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action. J Cell Commun Signal 2021. [PMID: 34173964 DOI: 10.1007/s12079-021-00630-6] [Reference Citation Analysis]
22 Schoeder CT, Kaleta M, Mahardhika AB, Olejarz-Maciej A, Łażewska D, Kieć-Kononowicz K, Müller CE. Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18. Eur J Med Chem 2018;155:381-97. [PMID: 29902723 DOI: 10.1016/j.ejmech.2018.05.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
23 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Reference Citation Analysis]
24 Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, De Sanctis JB, Bermúdez V. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci 2021;22:10370. [PMID: 34638711 DOI: 10.3390/ijms221910370] [Reference Citation Analysis]
25 Tavares LP, Garcia CC, Vago JP, Queiroz-Junior CM, Galvão I, David BA, Rachid MA, Silva PM, Russo RC, Teixeira MM, Sousa LP. Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice. Am J Respir Cell Mol Biol 2016;55:24-34. [PMID: 26677751 DOI: 10.1165/rcmb.2015-0083OC] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
26 Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol 2020;20:254-67. [PMID: 31822793 DOI: 10.1038/s41577-019-0240-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 31.3] [Reference Citation Analysis]
27 Zhang L, Jia M, Sun T. The roles of special proresolving mediators in pain relief. Reviews in the Neurosciences 2018;29:645-60. [DOI: 10.1515/revneuro-2017-0074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
28 Anderson GP. Advances in understanding COPD. F1000Res 2016;5:F1000 Faculty Rev-2392. [PMID: 27746898 DOI: 10.12688/f1000research.7018.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
29 Ulu A, Sahoo PK, Yuil-Valdes AG, Mukherjee M, Van Ormer M, Muthuraj PG, Thompson M, Anderson Berry A, Hanson CK, Natarajan SK, Nordgren TM. Omega-3 Fatty Acid-Derived Resolvin D2 Regulates Human Placental Vascular Smooth Muscle and Extravillous Trophoblast Activities. Int J Mol Sci 2019;20:E4402. [PMID: 31500240 DOI: 10.3390/ijms20184402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Ichiki T, Koga T, Yokomizo T. Receptor for Advanced Glycation End Products Regulates Leukotriene B4 Receptor 1 Signaling. DNA Cell Biol 2016;35:747-50. [PMID: 27830944 DOI: 10.1089/dna.2016.3552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
31 Khakpour S, Wilhelmsen K, Hellman J. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immun 2015;21:827-46. [DOI: 10.1177/1753425915606525] [Cited by in Crossref: 111] [Cited by in F6Publishing: 98] [Article Influence: 15.9] [Reference Citation Analysis]
32 Deyama S, Minami M, Kaneda K. Resolvins as potential candidates for the treatment of major depressive disorder. J Pharmacol Sci 2021;147:33-9. [PMID: 34294370 DOI: 10.1016/j.jphs.2021.05.002] [Reference Citation Analysis]
33 An JU, Kim SE, Oh DK. Molecular insights into lipoxygenases for biocatalytic synthesis of diverse lipid mediators. Prog Lipid Res 2021;83:101110. [PMID: 34144023 DOI: 10.1016/j.plipres.2021.101110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Land WG. DAMP-Promoted Efferent Innate Immune Responses in Human Diseases: Inflammation. Damage-Associated Molecular Patterns in Human Diseases. Cham: Springer International Publishing; 2020. pp. 151-209. [DOI: 10.1007/978-3-030-53868-2_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 2017;58:114-29. [PMID: 28336292 DOI: 10.1016/j.mam.2017.03.005] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 27.6] [Reference Citation Analysis]
36 Fattori V, Zaninelli TH, Rasquel-Oliveira FS, Casagrande R, Verri WA Jr. Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol Res 2020;151:104549. [PMID: 31743775 DOI: 10.1016/j.phrs.2019.104549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
37 Winkler JW, Libreros S, De La Rosa X, Sansbury BE, Norris PC, Chiang N, Fichtner D, Keyes GS, Wourms N, Spite M, Serhan CN. Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation. J Leukoc Biol 2018. [PMID: 29377345 DOI: 10.1002/JLB.3MI0617-254R] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
38 Kytikova O, Novgorodtseva T, Denisenko Y, Antonyuk M, Gvozdenko T. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma. Medicina (Kaunas) 2019;55:E284. [PMID: 31216723 DOI: 10.3390/medicina55060284] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
39 Cioccari L, Luethi N, Masoodi M. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine. Front Immunol 2020;11:599853. [PMID: 33324417 DOI: 10.3389/fimmu.2020.599853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Marrone MC, Coccurello R. Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases. Biomolecules 2019;10:E12. [PMID: 31861745 DOI: 10.3390/biom10010012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
41 Siddiqui YD, Omori K, Ito T, Yamashiro K, Nakamura S, Okamoto K, Ono M, Yamamoto T, Van Dyke TE, Takashiba S. Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis. Front Immunol 2019;10:307. [PMID: 30863409 DOI: 10.3389/fimmu.2019.00307] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
42 Zuo G, Zhang D, Mu R, Shen H, Li X, Wang Z, Li H, Chen G. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats. Mol Brain 2018;11:9. [PMID: 29439730 DOI: 10.1186/s13041-018-0351-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
43 Guimarães RC, Gonçalves TT, Leiria LO. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. Br J Pharmacol 2021;178:531-49. [PMID: 33169375 DOI: 10.1111/bph.15321] [Reference Citation Analysis]
44 Gc JB, Szlenk CT, Gao J, Dong X, Wang Z, Natesan S. Molecular Dynamics Simulations Provide Insight into the Loading Efficiency of Proresolving Lipid Mediators Resolvin D1 and D2 in Cell Membrane-Derived Nanovesicles. Mol Pharm 2020;17:2155-64. [PMID: 32374613 DOI: 10.1021/acs.molpharmaceut.0c00299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Aghasafari P, George U, Pidaparti R. A review of inflammatory mechanism in airway diseases. Inflamm Res 2019;68:59-74. [PMID: 30306206 DOI: 10.1007/s00011-018-1191-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 14.3] [Reference Citation Analysis]
46 Zhou M, Lyu Y, Zhu Y, Jiang T, Wu C, Yang J, Wang L. Effect of Ulinastatin Combined With Dexmedetomidine on Postoperative Cognitive Dysfunction in Patients Who Underwent Cardiac Surgery. Front Neurol 2019;10:1293. [PMID: 31920917 DOI: 10.3389/fneur.2019.01293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
47 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
48 Tao X, Lee MS, Donnelly CR, Ji RR. Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain. Neurotherapeutics 2020;17:886-99. [PMID: 32696274 DOI: 10.1007/s13311-020-00892-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
49 Kotańska M, Mika K, Szafarz M, Kubacka M, Müller CE, Sapa J, Kieć-Kononowicz K. Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating. Pharmaceuticals (Basel) 2021;14:270. [PMID: 33809564 DOI: 10.3390/ph14030270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Fabisiak A, Fabisiak N, Mokrowiecka A, Malecka-Panas E, Jacenik D, Kordek R, Zielińska M, Kieć-Kononowicz K, Fichna J. Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain. Neurogastroenterol Motil 2021;33:e14003. [PMID: 33058313 DOI: 10.1111/nmo.14003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Chamani S, Bianconi V, Tasbandi A, Pirro M, Barreto GE, Jamialahmadi T, Sahebkar A. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins. Mediators Inflamm 2020;2020:3267172. [PMID: 32308554 DOI: 10.1155/2020/3267172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
52 Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med 2018;64:1-17. [PMID: 28802833 DOI: 10.1016/j.mam.2017.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 106] [Article Influence: 18.4] [Reference Citation Analysis]
53 Lee CH. Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids. Cancers (Basel) 2019;11:E1841. [PMID: 31766574 DOI: 10.3390/cancers11121841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Tavares LP, Negreiros-Lima GL, Lima KM, E Silva PMR, Pinho V, Teixeira MM, Sousa LP. Blame the signaling: Role of cAMP for the resolution of inflammation. Pharmacol Res 2020;159:105030. [PMID: 32562817 DOI: 10.1016/j.phrs.2020.105030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
55 Zhang MJ, Sansbury BE, Hellmann J, Baker JF, Guo L, Parmer CM, Prenner JC, Conklin DJ, Bhatnagar A, Creager MA, Spite M. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation. Circulation 2016;134:666-80. [PMID: 27507404 DOI: 10.1161/CIRCULATIONAHA.116.021894] [Cited by in Crossref: 55] [Cited by in F6Publishing: 33] [Article Influence: 9.2] [Reference Citation Analysis]
56 Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263. [PMID: 34248142 DOI: 10.1038/s41392-021-00658-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Vanderwall AG, Milligan ED. Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management. Front Immunol 2019;10:3009. [PMID: 31921220 DOI: 10.3389/fimmu.2019.03009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
58 Perna E, Aguilera-Lizarraga J, Florens MV, Jain P, Theofanous SA, Hanning N, De Man JG, Berg M, De Winter B, Alpizar YA, Talavera K, Vanden Berghe P, Wouters M, Boeckxstaens G. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS. Gut. 2020 epub ahead of print. [PMID: 33023902 DOI: 10.1136/gutjnl-2020-321530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Zaninelli TH, Fattori V, Verri WA Jr. Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators' Contribution to Arthritis Physiopathology and Future Perspectives. Front Physiol 2021;12:729134. [PMID: 34539449 DOI: 10.3389/fphys.2021.729134] [Reference Citation Analysis]
60 Thornton JM, Walker JM, Sundarasivarao PYK, Spur BW, Rodriguez A, Yin K. Lipoxin A4 promotes reduction and antibiotic efficacy against Pseudomonas aeruginosa biofilm. Prostaglandins Other Lipid Mediat 2021;152:106505. [PMID: 33152529 DOI: 10.1016/j.prostaglandins.2020.106505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Deyama S, Ishikawa Y, Yoshikawa K, Shimoda K, Ide S, Satoh M, Minami M. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway. Int J Neuropsychopharmacol 2017;20:575-84. [PMID: 28419244 DOI: 10.1093/ijnp/pyx023] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
62 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
63 Han YH, Shin KO, Kim JY, Khadka DB, Kim HJ, Lee YM, Cho WJ, Cha JY, Lee BJ, Lee MO. A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. J Clin Invest 2019;129:1684-98. [PMID: 30855276 DOI: 10.1172/JCI124219] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
64 Buechler C, Pohl R, Aslanidis C. Pro-Resolving Molecules-New Approaches to Treat Sepsis? Int J Mol Sci 2017;18:E476. [PMID: 28241480 DOI: 10.3390/ijms18030476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
65 Hellmann J, Sansbury BE, Wong B, Li X, Singh M, Nuutila K, Chiang N, Eriksson E, Serhan CN, Spite M. Biosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair. J Invest Dermatol 2018;138:2051-60. [PMID: 29559341 DOI: 10.1016/j.jid.2018.03.1498] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
66 Weylandt KH. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell. Eur J Pharmacol 2016;785:108-15. [PMID: 26546723 DOI: 10.1016/j.ejphar.2015.11.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
67 Dalli J, Serhan C. Macrophage Proresolving Mediators-the When and Where. Microbiol Spectr 2016;4. [PMID: 27337457 DOI: 10.1128/microbiolspec.MCHD-0001-2014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
68 Doran AC. Inflammation Resolution: Implications for Atherosclerosis. Circ Res 2022;130:130-48. [PMID: 34995137 DOI: 10.1161/CIRCRESAHA.121.319822] [Reference Citation Analysis]
69 Sobrino A, Walker ME, Colas RA, Dalli J. Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators. PLoS One 2020;15:e0242543. [PMID: 33326419 DOI: 10.1371/journal.pone.0242543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Decker C, Sadhu S, Fredman G. Pro-Resolving Ligands Orchestrate Phagocytosis. Front Immunol 2021;12:660865. [PMID: 34177900 DOI: 10.3389/fimmu.2021.660865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Thornton JM, Yin K. Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence. Molecules 2021;26:6970. [PMID: 34834062 DOI: 10.3390/molecules26226970] [Reference Citation Analysis]
72 Lämmermann T. In the eye of the neutrophil swarm-navigation signals that bring neutrophils together in inflamed and infected tissues. J Leukoc Biol 2016;100:55-63. [PMID: 26416718 DOI: 10.1189/jlb.1MR0915-403] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 8.1] [Reference Citation Analysis]
73 Sommakia S, Baker OJ. Regulation of inflammation by lipid mediators in oral diseases. Oral Dis 2017;23:576-97. [PMID: 27426637 DOI: 10.1111/odi.12544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
74 Koenis DS, Beegun I, Jouvene CC, Aguirre GA, Souza PR, Gonzalez-Nunez M, Ly L, Pistorius K, Kocher HM, Ricketts W, Thomas G, Perretti M, Alusi G, Pfeffer P, Dalli J. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19. Circ Res 2021;129:e54-71. [PMID: 34238021 DOI: 10.1161/CIRCRESAHA.121.319142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Martindale RG, Warren MM, McClave SA. Does the use of specialized proresolving molecules in critical care offer a more focused approach to controlling inflammation than that of fish oils? Curr Opin Clin Nutr Metab Care 2016;19:151-4. [PMID: 26828585 DOI: 10.1097/MCO.0000000000000250] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
76 Sima C, Montero E, Nguyen D, Freire M, Norris P, Serhan CN, Van Dyke TE. ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance. Sci Rep 2017;7:12848. [PMID: 28993702 DOI: 10.1038/s41598-017-13185-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
77 Müller CE. [Progress in cannabis research from a pharmaceutical chemist's point of view]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2019;62:818-24. [PMID: 31161229 DOI: 10.1007/s00103-019-02964-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
78 Susai SR, Mongan D, Healy C, Cannon M, Nelson B, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Föcking M, Cotter D, Amminger GP. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial. Brain Behav Immun 2021;99:147-56. [PMID: 34624483 DOI: 10.1016/j.bbi.2021.09.018] [Reference Citation Analysis]
79 Iwamoto S, Koga T, Ohba M, Okuno T, Koike M, Murakami A, Matsuda A, Yokomizo T. Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2. Sci Rep 2017;7:13267. [PMID: 29038497 DOI: 10.1038/s41598-017-13122-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
80 Kim AS, Conte MS. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Advanced Drug Delivery Reviews 2020;159:170-9. [DOI: 10.1016/j.addr.2020.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
81 Lannan KL, Spinelli SL, Blumberg N, Phipps RP. Maresin 1 induces a novel pro-resolving phenotype in human platelets. J Thromb Haemost 2017;15:802-13. [PMID: 28079976 DOI: 10.1111/jth.13620] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
82 Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol 2018;19:654-72. [PMID: 30104701 DOI: 10.1038/s41580-018-0044-8] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 38.3] [Reference Citation Analysis]
83 Mizuno H, Kihara Y. Druggable Lipid GPCRs: Past, Present, and Prospects. Adv Exp Med Biol 2020;1274:223-58. [PMID: 32894513 DOI: 10.1007/978-3-030-50621-6_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
84 Duvall MG, Bruggemann TR, Levy BD. Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation. Mol Aspects Med 2017;58:44-56. [PMID: 28455109 DOI: 10.1016/j.mam.2017.04.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
85 Dalli J, Serhan CN. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol 2019;176:1024-37. [PMID: 29679485 DOI: 10.1111/bph.14336] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
86 Lopategi A, Flores-Costa R, Rius B, López-Vicario C, Alcaraz-Quiles J, Titos E, Clària J. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome. J Leukoc Biol 2019;105:25-36. [PMID: 29601102 DOI: 10.1002/JLB.3HI0517-206RR] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
87 López-Vales R, David S. Bioactive Lipids in Inflammation After Central Nervous System Injury. Adv Exp Med Biol 2019;1127:181-94. [PMID: 31140179 DOI: 10.1007/978-3-030-11488-6_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
88 Croasdell A, Sime PJ, Phipps RP. Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes. FASEB J 2016;30:3181-93. [PMID: 27256622 DOI: 10.1096/fj.201600375R] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
89 Norling LV, Headland SE, Dalli J, Arnardottir HH, Haworth O, Jones HR, Irimia D, Serhan CN, Perretti M. Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. JCI Insight 2016;1:e85922. [PMID: 27158677 DOI: 10.1172/jci.insight.85922] [Cited by in Crossref: 93] [Cited by in F6Publishing: 94] [Article Influence: 15.5] [Reference Citation Analysis]
90 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
91 Biringer RG. Endocannabinoid signaling pathways: beyond CB1R and CB2R. J Cell Commun Signal 2021;15:335-60. [PMID: 33978927 DOI: 10.1007/s12079-021-00622-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Miao Z, Schultzberg M, Wang X, Zhao Y. Role of polyunsaturated fatty acids in ischemic stroke - A perspective of specialized pro-resolving mediators. Clin Nutr 2021;40:2974-87. [PMID: 33509668 DOI: 10.1016/j.clnu.2020.12.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
93 Kang GJ, Kim EJ, Lee CH. Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation. Antioxidants (Basel) 2020;9:E1259. [PMID: 33321955 DOI: 10.3390/antiox9121259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
94 Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators. ALX receptor ligands define a biochemical endotype for severe asthma. JCI Insight 2017;2:93534. [PMID: 28724795 DOI: 10.1172/jci.insight.93534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
95 Pascoal LB, Bombassaro B, Ramalho AF, Coope A, Moura RF, Correa-da-Silva F, Ignacio-Souza L, Razolli D, de Oliveira D, Catharino R, Velloso LA. Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity. J Neuroinflammation 2017;14:5. [PMID: 28086928 DOI: 10.1186/s12974-016-0777-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
96 Jordan PM, Werz O. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections. FEBS J 2021. [PMID: 34741578 DOI: 10.1111/febs.16266] [Reference Citation Analysis]
97 Krishnamoorthy N, Abdulnour RE, Walker KH, Engstrom BD, Levy BD. Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiol Rev 2018;98:1335-70. [PMID: 29717929 DOI: 10.1152/physrev.00026.2017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
98 Khaddaj-Mallat R, Morin C, Rousseau É. Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: Anti-inflammatory and anti-proliferative effects. Eur J Pharmacol 2016;792:70-7. [PMID: 27818127 DOI: 10.1016/j.ejphar.2016.10.038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
99 Park J, Langmead CJ, Riddy DM. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery. ACS Pharmacol Transl Sci 2020;3:88-106. [PMID: 32259091 DOI: 10.1021/acsptsci.9b00075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
100 Duan J, Song Y, Zhang X, Wang C. Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders. Front Physiol 2021;12:646491. [PMID: 34113260 DOI: 10.3389/fphys.2021.646491] [Reference Citation Analysis]
101 Negreiros-Lima GL, Lima KM, Moreira IZ, Jardim BLO, Vago JP, Galvão I, Teixeira LCR, Pinho V, Teixeira MM, Sugimoto MA, Sousa LP. Cyclic AMP Regulates Key Features of Macrophages via PKA: Recruitment, Reprogramming and Efferocytosis. Cells 2020;9:E128. [PMID: 31935860 DOI: 10.3390/cells9010128] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
102 Dalli J, Gomez EA, Jouvene CC. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease. Biomolecules 2022;12:353. [DOI: 10.3390/biom12030353] [Reference Citation Analysis]
103 Payrits M, Horváth Á, Biró-Sütő T, Erostyák J, Makkai G, Sághy É, Pohóczky K, Kecskés A, Kecskés M, Szolcsányi J, Helyes Z, Szőke É. Resolvin D1 and D2 Inhibit Transient Receptor Potential Vanilloid 1 and Ankyrin 1 Ion Channel Activation on Sensory Neurons via Lipid Raft Modification. Int J Mol Sci 2020;21:E5019. [PMID: 32708653 DOI: 10.3390/ijms21145019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
104 Arienti S, Barth ND, Dorward DA, Rossi AG, Dransfield I. Regulation of Apoptotic Cell Clearance During Resolution of Inflammation. Front Pharmacol 2019;10:891. [PMID: 31456686 DOI: 10.3389/fphar.2019.00891] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
105 Luo X, Gu Y, Tao X, Serhan CN, Ji RR. Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy. Front Pharmacol 2019;10:745. [PMID: 31333464 DOI: 10.3389/fphar.2019.00745] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
106 Kalinec GM, Lomberk G, Urrutia RA, Kalinec F. Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss. Front Cell Neurosci 2017;11:192. [PMID: 28736517 DOI: 10.3389/fncel.2017.00192] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 10.4] [Reference Citation Analysis]
107 Sima C, Paster B, Van Dyke TE. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes. Crit Rev Immunol 2018;38:343-65. [PMID: 30806214 DOI: 10.1615/CritRevImmunol.2018026750] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
108 Sansbury BE, Spite M. Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology. Circ Res 2016;119:113-30. [PMID: 27340271 DOI: 10.1161/CIRCRESAHA.116.307308] [Cited by in Crossref: 91] [Cited by in F6Publishing: 48] [Article Influence: 18.2] [Reference Citation Analysis]
109 Fredman G, Spite M. Specialized pro-resolving mediators in cardiovascular diseases. Mol Aspects Med 2017;58:65-71. [PMID: 28257820 DOI: 10.1016/j.mam.2017.02.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
110 Flak MB, Koenis DS, Sobrino A, Smith J, Pistorius K, Palmas F, Dalli J. GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections. J Clin Invest 2020;130:359-73. [PMID: 31793912 DOI: 10.1172/JCI131609] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
111 Neumann A, Engel V, Mahardhika AB, Schoeder CT, Namasivayam V, Kieć-Kononowicz K, Müller CE. Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18. Biomolecules 2020;10:E686. [PMID: 32365486 DOI: 10.3390/biom10050686] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
112 Giannakis N, Sansbury BE, Patsalos A, Hays TT, Riley CO, Han X, Spite M, Nagy L. Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration. Nat Immunol 2019;20:626-36. [PMID: 30936495 DOI: 10.1038/s41590-019-0356-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
113 Seneviratne A, Han Y, Wong E, Walter ERH, Jiang L, Cave L, Long NJ, Carling D, Mason JC, Haskard DO, Boyle JJ. Hematoma Resolution In Vivo Is Directed by Activating Transcription Factor 1. Circ Res 2020;127:928-44. [PMID: 32611235 DOI: 10.1161/CIRCRESAHA.119.315528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
114 Gilroy DW, Bishop-Bailey D. Lipid mediators in immune regulation and resolution. Br J Pharmacol 2019;176:1009-23. [PMID: 30674066 DOI: 10.1111/bph.14587] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
115 Botten N, Hodges RR, Li D, Bair JA, Shatos MA, Utheim TP, Serhan CN, Dartt DA. Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells. FASEB J 2019;33:8468-78. [PMID: 31013438 DOI: 10.1096/fj.201802467R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
116 Garcia-So J, Zhang X, Yang X, Rubinstein MR, Mao Y, Kitajewski J, Liu K, Han YW. Omega-3 fatty acids suppress Fusobacterium nucleatum-induced placental inflammation originating from maternal endothelial cells. JCI Insight 2019;4:125436. [PMID: 30728337 DOI: 10.1172/jci.insight.125436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
117 Ferguson B, Bokka NR, Maddipati KR, Ayilavarapu S, Weltman R, Zhu L, Chen W, Zheng WJ, Angelov N, Van Dyke TE, Lee CT. Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation. Front Immunol 2020;11:1307. [PMID: 32670289 DOI: 10.3389/fimmu.2020.01307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
118 Guerrero-Alba R, Barragán-Iglesias P, González-Hernández A, Valdez-Moráles EE, Granados-Soto V, Condés-Lara M, Rodríguez MG, Marichal-Cancino BA. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. Front Pharmacol 2018;9:1496. [PMID: 30670965 DOI: 10.3389/fphar.2018.01496] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
119 Zurier RB, Burstein SH. Cannabinoids, inflammation, and fibrosis. FASEB j 2016;30:3682-9. [DOI: 10.1096/fj.201600646r] [Cited by in Crossref: 53] [Cited by in F6Publishing: 25] [Article Influence: 8.8] [Reference Citation Analysis]
120 Norling LV, Ly L, Dalli J. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators. Curr Opin Clin Nutr Metab Care 2017;20:145-52. [PMID: 28002074 DOI: 10.1097/MCO.0000000000000353] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
121 Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J, Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M, Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Front Immunol 2019;10:1699. [PMID: 31396220 DOI: 10.3389/fimmu.2019.01699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
122 Vickery TW, Armstrong M, Kofonow JM, Robertson CE, Kroehl ME, Reisdorph NA, Ramakrishnan VR, Frank DN. Altered tissue specialized pro-resolving mediators in chronic rhinosinusitis. Prostaglandins Leukot Essent Fatty Acids 2021;164:102218. [PMID: 33338738 DOI: 10.1016/j.plefa.2020.102218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
123 Morales P, Reggio PH. An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors. Cannabis Cannabinoid Res 2017;2:265-73. [PMID: 29098189 DOI: 10.1089/can.2017.0036] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 14.8] [Reference Citation Analysis]
124 Brennan EP, Cacace A, Godson C. Specialized pro-resolving mediators in renal fibrosis. Mol Aspects Med 2017;58:102-13. [PMID: 28479307 DOI: 10.1016/j.mam.2017.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
125 He W, Zhang Z, Sha X. Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke. Biomaterials 2021;277:121111. [PMID: 34488117 DOI: 10.1016/j.biomaterials.2021.121111] [Reference Citation Analysis]
126 Codagnone M, Cianci E, Lamolinara A, Mari VC, Nespoli A, Isopi E, Mattoscio D, Arita M, Bragonzi A, Iezzi M, Romano M, Recchiuti A. Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. Mucosal Immunol 2018;11:35-49. [PMID: 28422188 DOI: 10.1038/mi.2017.36] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
127 Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev 2020;159:133-69. [PMID: 32628989 DOI: 10.1016/j.addr.2020.06.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
128 Romano M, Patruno S, Pomilio A, Recchiuti A. Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review. Stem Cells Transl Med 2019;8:992-8. [PMID: 31187940 DOI: 10.1002/sctm.19-0078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
129 Shan K, Feng N, Cui J, Wang S, Qu H, Fu G, Li J, Chen H, Wang X, Wang R, Qi Y, Gu Z, Chen YQ. Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization. J Cell Mol Med 2020;24:8045-56. [PMID: 32469149 DOI: 10.1111/jcmm.15436] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
130 Singh NK, Rao GN. Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. Prog Lipid Res 2019;73:28-45. [PMID: 30472260 DOI: 10.1016/j.plipres.2018.11.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 12.8] [Reference Citation Analysis]
131 Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 2016;785:144-55. [PMID: 26546247 DOI: 10.1016/j.ejphar.2015.11.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
132 Ganesan R, Henkels KM, Shah K, De La Rosa X, Libreros S, Cheemarla NR, Serhan CN, Gomez-Cambronero J. D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution. FASEB J 2020;34:15888-906. [PMID: 33047359 DOI: 10.1096/fj.201903025RR] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Schoeder CT, Mahardhika AB, Drabczyńska A, Kieć-Kononowicz K, Müller CE. Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18. ACS Med Chem Lett 2020;11:2024-31. [PMID: 33062188 DOI: 10.1021/acsmedchemlett.0c00208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
134 Shinohara M, Serhan CN. Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation. J Atheroscler Thromb 2016;23:655-64. [PMID: 27052783 DOI: 10.5551/jat.33928] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
135 Chiang N, de la Rosa X, Libreros S, Serhan CN. Novel Resolvin D2 Receptor Axis in Infectious Inflammation. J Immunol 2017;198:842-51. [PMID: 27994074 DOI: 10.4049/jimmunol.1601650] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 12.8] [Reference Citation Analysis]
136 Ma C, Vasu R, Zhang H. The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease. Mediators Inflamm 2019;2019:8495913. [PMID: 31780872 DOI: 10.1155/2019/8495913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
137 Clària J, López-vicario C, Rius B, Titos E. Pro-resolving actions of SPM in adipose tissue biology. Molecular Aspects of Medicine 2017;58:83-92. [DOI: 10.1016/j.mam.2017.03.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
138 Fullerton MS, Colonne PM, Dragan AL, Brann KR, Kurten RC, Voth DE. Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells. mSphere 2021;6:e0044221. [PMID: 34232075 DOI: 10.1128/mSphere.00442-21] [Reference Citation Analysis]
139 Ma Y. Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction. Cells 2021;10:1676. [PMID: 34359844 DOI: 10.3390/cells10071676] [Reference Citation Analysis]
140 Fredman G, Sadhu S, Rymut N. Fine-tuning inflammation-resolution programs: focus on atherosclerosis. Curr Opin Clin Nutr Metab Care 2017;20:117-23. [PMID: 27984234 DOI: 10.1097/MCO.0000000000000351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
141 Lee CH. Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm. Arch Pharm Res 2021;44:84-98. [PMID: 33398691 DOI: 10.1007/s12272-020-01299-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
142 Cortés Fuentes IA, Burotto M, Retamal MA, Frelinghuysen M, Caglevic C, Gormaz JG. Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy. Free Radic Biol Med 2020;160:263-76. [PMID: 32827639 DOI: 10.1016/j.freeradbiomed.2020.07.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Walker JM, Sundarasivarao PYK, Thornton JM, Sochacki K, Rodriguez A, Spur BW, Acharya NK, Yin K. Resolvin D2 promotes host defense in a 2 - hit model of sepsis with secondary lung infection. Prostaglandins Other Lipid Mediat 2022;159:106617. [PMID: 35007703 DOI: 10.1016/j.prostaglandins.2022.106617] [Reference Citation Analysis]
144 Diaz LA, Altman NH, Khan WN, Serhan CN, Adkins B. Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection. Infect Immun 2017;85:e00464-17. [PMID: 28694292 DOI: 10.1128/IAI.00464-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
145 Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 2018;128:2657-69. [PMID: 29757195 DOI: 10.1172/JCI97943] [Cited by in Crossref: 410] [Cited by in F6Publishing: 250] [Article Influence: 102.5] [Reference Citation Analysis]
146 Viola JR, Lemnitzer P, Jansen Y, Csaba G, Winter C, Neideck C, Silvestre-Roig C, Dittmar G, Döring Y, Drechsler M, Weber C, Zimmer R, Cenac N, Soehnlein O. Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice. Circ Res 2016;119:1030-8. [PMID: 27531933 DOI: 10.1161/CIRCRESAHA.116.309492] [Cited by in Crossref: 106] [Cited by in F6Publishing: 77] [Article Influence: 17.7] [Reference Citation Analysis]
147 Brennan E, Kantharidis P, Cooper ME, Godson C. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol 2021. [PMID: 34282342 DOI: 10.1038/s41581-021-00454-y] [Reference Citation Analysis]
148 Mizraji G, Heyman O, Van Dyke TE, Wilensky A. Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis. Front Immunol 2018;9:785. [PMID: 29922275 DOI: 10.3389/fimmu.2018.00785] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
149 Son SE, Park SJ, Koh JM, Im DS. Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice. Acta Pharmacol Sin 2020;41:1337-47. [PMID: 32555509 DOI: 10.1038/s41401-020-0435-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Pirault J, Bäck M. Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease. Front Pharmacol 2018;9:1273. [PMID: 30487747 DOI: 10.3389/fphar.2018.01273] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
151 Roh J, Go EJ, Park JW, Kim YH, Park CK. Resolvins: Potent Pain Inhibiting Lipid Mediators via Transient Receptor Potential Regulation. Front Cell Dev Biol 2020;8:584206. [PMID: 33363143 DOI: 10.3389/fcell.2020.584206] [Reference Citation Analysis]
152 Bardin M, Pawelzik SC, Lagrange J, Mahdi A, Arnardottir H, Regnault V, Fève B, Lacolley P, Michel JB, Mercier N, Bäck M. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice. Biochem Pharmacol 2022;:115075. [PMID: 35525326 DOI: 10.1016/j.bcp.2022.115075] [Reference Citation Analysis]
153 Mosser DM, Hamidzadeh K, Goncalves R. Macrophages and the maintenance of homeostasis. Cell Mol Immunol 2021;18:579-87. [PMID: 32934339 DOI: 10.1038/s41423-020-00541-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
154 Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 2016;15:551-67. [PMID: 27020098 DOI: 10.1038/nrd.2016.39] [Cited by in Crossref: 361] [Cited by in F6Publishing: 335] [Article Influence: 60.2] [Reference Citation Analysis]
155 Sulciner ML, Serhan CN, Gilligan MM, Mudge DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli J, Greene ER, Gus-Brautbar Y, Piwowarski J, Mammoto T, Zurakowski D, Perretti M, Sukhatme VP, Kaipainen A, Kieran MW, Huang S, Panigrahy D. Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med 2018;215:115-40. [PMID: 29191914 DOI: 10.1084/jem.20170681] [Cited by in Crossref: 105] [Cited by in F6Publishing: 111] [Article Influence: 21.0] [Reference Citation Analysis]
156 Tułowiecka N, Kotlęga D, Prowans P, Szczuko M. The Role of Resolvins: EPA and DHA Derivatives Can Be Useful in the Prevention and Treatment of Ischemic Stroke. Int J Mol Sci 2020;21:E7628. [PMID: 33076354 DOI: 10.3390/ijms21207628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
157 Xiang MS, Tan JK, Macia L. Fatty Acids, Gut Bacteria, and Immune Cell Function. The Molecular Nutrition of Fats. Elsevier; 2019. pp. 151-64. [DOI: 10.1016/b978-0-12-811297-7.00011-1] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
158 Dong X, Gao J, Zhang CY, Hayworth C, Frank M, Wang Z. Neutrophil Membrane-Derived Nanovesicles Alleviate Inflammation To Protect Mouse Brain Injury from Ischemic Stroke. ACS Nano 2019;13:1272-83. [PMID: 30673266 DOI: 10.1021/acsnano.8b06572] [Cited by in Crossref: 25] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
159 Briottet M, Shum M, Urbach V. The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease. Front Pharmacol 2020;11:1290. [PMID: 32982730 DOI: 10.3389/fphar.2020.01290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
160 Arnardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol 2016;9:757-66. [PMID: 26462421 DOI: 10.1038/mi.2015.99] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
161 Pham TL, Bazan HEP. Docosanoid signaling modulates corneal nerve regeneration: effect on tear secretion, wound healing, and neuropathic pain. J Lipid Res 2021;62:100033. [PMID: 32788291 DOI: 10.1194/jlr.TR120000954] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
162 Motwani MP, Colas RA, George MJ, Flint JD, Dalli J, Richard-Loendt A, De Maeyer RP, Serhan CN, Gilroy DW. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation. JCI Insight 2018;3:94463. [PMID: 29563331 DOI: 10.1172/jci.insight.94463] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
163 Das UN. Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS. Lipids Health Dis 2016;15:206. [PMID: 27887602 DOI: 10.1186/s12944-016-0377-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
164 Serhan CN, de la Rosa X, Jouvene C. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation. J Intern Med 2019;286:240-58. [PMID: 30565762 DOI: 10.1111/joim.12871] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
165 Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther 2021;218:107670. [PMID: 32891711 DOI: 10.1016/j.pharmthera.2020.107670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
166 Colas RA, Nhat LTH, Thuong NTT, Gómez EA, Ly L, Thanh HH, Mai NTH, Phu NH, Thwaites GE, Dalli J. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis. FASEB J 2019;33:13028-39. [PMID: 31500466 DOI: 10.1096/fj.201901590R] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 6.7] [Reference Citation Analysis]
167 Dragano NR, Monfort-pires M, Velloso LA. Mechanisms Mediating the Actions of Fatty Acids in the Hypothalamus. Neuroscience 2020;447:15-27. [DOI: 10.1016/j.neuroscience.2019.10.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
168 Sumida H, Cyster JG. G-Protein Coupled Receptor 18 Contributes to Establishment of the CD8 Effector T Cell Compartment. Front Immunol 2018;9:660. [PMID: 29670628 DOI: 10.3389/fimmu.2018.00660] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
169 Recchiuti A, Isopi E, Romano M, Mattoscio D. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation. Int J Mol Sci 2020;21:E6637. [PMID: 32927853 DOI: 10.3390/ijms21186637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Ichiki T, Koga T, Okuno T, Saeki K, Yamamoto Y, Yamamoto H, Sakaguchi M, Yokomizo T. Modulation of leukotriene B 4 receptor 1 signaling by receptor for advanced glycation end products (RAGE). FASEB j 2015;30:1811-22. [DOI: 10.1096/fj.201500117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
171 Qu L, Caterina MJ. Accelerating the reversal of inflammatory pain with NPD1 and its receptor GPR37. J Clin Invest 2018;128:3246-9. [PMID: 30010628 DOI: 10.1172/JCI122203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
172 Kudo K, Miki Y, Carreras J, Nakayama S, Nakamoto Y, Ito M, Nagashima E, Yamamoto K, Higuchi H, Morita SY, Inoue A, Aoki J, Ando K, Nakamura N, Murakami M, Kotani A. Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma. Cell Metab 2022:S1550-4131(22)00083-3. [PMID: 35294862 DOI: 10.1016/j.cmet.2022.02.011] [Reference Citation Analysis]
173 Wang RX, Colgan SP. Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses. Mol Aspects Med 2017;58:93-101. [PMID: 28232096 DOI: 10.1016/j.mam.2017.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
174 Brennan E, Mohan M, Andrews D, Bose M, Kantharidis P. Specialized pro-resolving mediators in diabetes: novel therapeutic strategies. Clinical Science 2019;133:2121-41. [DOI: 10.1042/cs20190067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
175 Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy. Am J Pathol 2017;187:1211-21. [PMID: 28527709 DOI: 10.1016/j.ajpath.2017.01.018] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 17.4] [Reference Citation Analysis]
176 Gu Z, Lamont GJ, Lamont RJ, Uriarte SM, Wang H, Scott DA. Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes. Innate Immun 2016;22:186-95. [PMID: 26878867 DOI: 10.1177/1753425916628618] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
177 Clarke TL, Johnson RL, Simone JJ, Carlone RL. The Endocannabinoid System and Invertebrate Neurodevelopment and Regeneration. Int J Mol Sci 2021;22:2103. [PMID: 33672634 DOI: 10.3390/ijms22042103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
178 Mei Y, Fang C, Ding S, Liu X, Hu J, Xu J, Mei Q. PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway. International Immunopharmacology 2019;75:105776. [DOI: 10.1016/j.intimp.2019.105776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
179 Livne-Bar I, Wei J, Liu HH, Alqawlaq S, Won GJ, Tuccitto A, Gronert K, Flanagan JG, Sivak JM. Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury. J Clin Invest 2017;127:4403-14. [PMID: 29106385 DOI: 10.1172/JCI77398] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
180 Barden AE, Mas E, Mori TA. n-3 Fatty acid supplementation and proresolving mediators of inflammation. Curr Opin Lipidol 2016;27:26-32. [PMID: 26655290 DOI: 10.1097/MOL.0000000000000262] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
181 Kim N, Thatcher TH, Sime PJ, Phipps RP. Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients. JCI Insight 2017;2:e88588. [PMID: 28194434 DOI: 10.1172/jci.insight.88588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
182 Fredman G, MacNamara KC. Atherosclerosis is a Major Human Killer and Non-resolving Inflammation is a Prime Suspect. Cardiovasc Res 2021:cvab309. [PMID: 34609505 DOI: 10.1093/cvr/cvab309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Recchiuti A, Mattoscio D, Isopi E. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Front Pharmacol 2019;10:252. [PMID: 31001110 DOI: 10.3389/fphar.2019.00252] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
184 Thatcher TH, Woeller CF, McCarthy CE, Sime PJ. Quenching the fires: Pro-resolving mediators, air pollution, and smoking. Pharmacol Ther 2019;197:212-24. [PMID: 30759375 DOI: 10.1016/j.pharmthera.2019.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
185 Emre C, Arroyo-García LE, Do KV, Jun B, Ohshima M, Alcalde SG, Cothern ML, Maioli S, Nilsson P, Hjorth E, Fisahn A, Bazan NG, Schultzberg M. Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice. Commun Biol 2022;5:245. [PMID: 35314851 DOI: 10.1038/s42003-022-03169-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther 2021;:107879. [PMID: 33915177 DOI: 10.1016/j.pharmthera.2021.107879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
187 Alqahtani S, Xia L, Jannasch A, Ferreira C, Franco J, Shannahan JH. Disruption of pulmonary resolution mediators contribute to exacerbated silver nanoparticle-induced acute inflammation in a metabolic syndrome mouse model. Toxicol Appl Pharmacol 2021;431:115730. [PMID: 34601004 DOI: 10.1016/j.taap.2021.115730] [Reference Citation Analysis]
188 Joe Y, Chen Y, Park J, Kim HJ, Rah SY, Ryu J, Cho GJ, Choi HS, Ryter SW, Park JW, Kim UH, Chung HT. Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis. Cell Rep 2020;30:1063-1076.e5. [PMID: 31995750 DOI: 10.1016/j.celrep.2019.12.090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
189 Wang JC, Strichartz GR. Prevention of Chronic Post-Thoracotomy Pain in Rats By Intrathecal Resolvin D1 and D2: Effectiveness of Perioperative and Delayed Drug Delivery. J Pain 2017;18:535-45. [PMID: 28063958 DOI: 10.1016/j.jpain.2016.12.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
190 Mayurasakorn K, Niatsetskaya ZV, Sosunov SA, Williams JJ, Zirpoli H, Vlasakov I, Deckelbaum RJ, Ten VS. DHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice. PLoS One 2016;11:e0160870. [PMID: 27513579 DOI: 10.1371/journal.pone.0160870] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
191 Fiala M, Kooij G, Wagner K, Hammock B, Pellegrini M. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J 2017;31:3229-39. [PMID: 28420693 DOI: 10.1096/fj.201700065R] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
192 Morales P, Lago-Fernandez A, Hurst DP, Sotudeh N, Brailoiu E, Reggio PH, Abood ME, Jagerovic N. Therapeutic Exploitation of GPR18: Beyond the Cannabinoids? J Med Chem 2020;63:14216-27. [PMID: 32914978 DOI: 10.1021/acs.jmedchem.0c00926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
193 Li Y, Wang J, Li Y, Liu C, Gong X, Zhuang Y, Chen L, Sun K. Identification of Immune-Related Genes in Sepsis due to Community-Acquired Pneumonia. Comput Math Methods Med 2021;2021:8020067. [PMID: 34484417 DOI: 10.1155/2021/8020067] [Reference Citation Analysis]
194 Silberberg E, Filep JG, Ariel A. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis. Front Immunol 2022;13:863449. [DOI: 10.3389/fimmu.2022.863449] [Reference Citation Analysis]
195 Al-Shaer AE, Buddenbaum N, Shaikh SR. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158936. [PMID: 33794384 DOI: 10.1016/j.bbalip.2021.158936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
196 Ward PA. Resolvins on the way to resolution. J Exp Med 2015;212:1142. [PMID: 26216604 DOI: 10.1084/jem.2128insight4] [Reference Citation Analysis]
197 Avanoǧlu Güler A, Rossi FW, Bellando-Randone S, Prevete N, Tufan A, Manetti M, de Paulis A, Matucci-Cerinic M. The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis. Front Immunol 2020;11:1249. [PMID: 32636845 DOI: 10.3389/fimmu.2020.01249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Miki Y, Kidoguchi Y, Sato M, Taketomi Y, Taya C, Muramatsu K, Gelb MH, Yamamoto K, Murakami M. Dual Roles of Group IID Phospholipase A2 in Inflammation and Cancer. J Biol Chem 2016;291:15588-601. [PMID: 27226632 DOI: 10.1074/jbc.M116.734624] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
199 Zhang L, Liu Z, Zhu Q, Wen S, Yang C, Fu Z, Sun T. Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18. Neurochem Res 2018;43:2384-92. [DOI: 10.1007/s11064-018-2666-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
200 Halade GV, Black LM, Verma MK. Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery. Biotechnol Adv 2018;36:935-53. [PMID: 29499340 DOI: 10.1016/j.biotechadv.2018.02.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
201 Dort J, Orfi Z, Fabre P, Molina T, Conte TC, Greffard K, Pellerito O, Bilodeau JF, Dumont NA. Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy. Nat Commun 2021;12:6264. [PMID: 34716330 DOI: 10.1038/s41467-021-26516-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
203 Kraft JD, Blomgran R, Lundgaard I, Quiding-Järbrink M, Bromberg JS, Börgeson E. Specialized Pro-Resolving Mediators and the Lymphatic System. Int J Mol Sci 2021;22:2750. [PMID: 33803130 DOI: 10.3390/ijms22052750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Lee CT, Li R, Zhu L, Tribble GD, Zheng WJ, Ferguson B, Maddipati KR, Angelov N, Van Dyke TE. Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation. Front Immunol 2021;12:691216. [PMID: 34177951 DOI: 10.3389/fimmu.2021.691216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
205 Colas RA, Dalli J, Chiang N, Vlasakov I, Sanger JM, Riley IR, Serhan CN. Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation. J Immunol 2016;197:4444-52. [PMID: 27799313 DOI: 10.4049/jimmunol.1600837] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
206 Sotudeh N, Morales P, Hurst DP, Lynch DL, Reggio PH. Towards A Molecular Understanding of The Cannabinoid Related Orphan Receptor GPR18: A Focus on Its Constitutive Activity. Int J Mol Sci 2019;20:E2300. [PMID: 31075933 DOI: 10.3390/ijms20092300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
207 Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther 2018;186:98-113. [PMID: 29352860 DOI: 10.1016/j.pharmthera.2018.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
208 Ge YJ, Liao QW, Xu YC, Zhao Q, Wu BL, Ye RD. Anti-inflammatory signaling through G protein-coupled receptors. Acta Pharmacol Sin 2020;41:1531-8. [PMID: 33060777 DOI: 10.1038/s41401-020-00523-1] [Reference Citation Analysis]